chr11-66526181-T-G

Variant summary

Our verdict is Pathogenic. The variant received 12 ACMG points: 14P and 2B. PS3PM1PP5_Very_StrongBP4BS2_Supporting

The NM_024649.5(BBS1):​c.1169T>G​(p.Met390Arg) variant causes a missense change. The variant allele was found at a frequency of 0.00268 in 1,614,180 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). ClinVar reports functional evidence for this variant: "SCV000373275: A homozygous knock-in mouse line carrying the Met390Arg variant showed a phenotype that included retinal degeneration, male infertility, and obesity (PMID:18032602)." and additional evidence is available in ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. M390V) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0020 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0027 ( 2 hom. )

Consequence

BBS1
NM_024649.5 missense

Scores

4
13
1

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:60O:2

Conservation

PhyloP100: 4.70

Publications

206 publications found
Variant links:
Genes affected
BBS1 (HGNC:966): (Bardet-Biedl syndrome 1) Mutations in this gene have been observed in patients with the major form (type 1) of Bardet-Biedl syndrome. The encoded protein may play a role in eye, limb, cardiac and reproductive system development. [provided by RefSeq, Jul 2008]
ZDHHC24 (HGNC:27387): (zinc finger DHHC-type containing 24) Predicted to enable protein-cysteine S-palmitoyltransferase activity. Predicted to be involved in peptidyl-L-cysteine S-palmitoylation and protein targeting to membrane. Predicted to be integral component of membrane. Predicted to be active in Golgi apparatus and endoplasmic reticulum. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 12 ACMG points.

PS3
PS3 evidence extracted from ClinVar submissions: SCV000373275: A homozygous knock-in mouse line carrying the Met390Arg variant showed a phenotype that included retinal degeneration, male infertility, and obesity (PMID: 18032602).; SCV001573536: Well-established functional studies show a deleterious effect (PS3).; SCV002058656: Functional studies provide strong evidence of the variant having a damaging effect on the gene or gene product (PMID: 12118255, 12677556, 22940089, 23143442).; SCV002503686: A knock-in mouse model homozygous for p.Met390Arg has cilia defects, and recapitulates aspects of the human BBS phenotype, including retinal degeneration, male infertility, and obesity (PMID: 18032602), and partial rescue (hypomorph) was demonstrated in a zebrafish assay (PMID: 20498079).; SCV000329106: Published functional studies demonstrate a damaging effect as mice homozygous for the M390R variant develop cilia defects, ventriculomegaly, retinopathy, and obesity (Davis et al., 2007);; SCV000253934: Experimental studies have shown that this missense change affects BBS1 function (PMID: 15314642, 18032602, 20498079).; SCV000699512: An in vivo BBS mouse model shows that mice homozygous for the M390R mutation recapitulate aspects of the human phenotype, including retinal degeneration, male infertility, and obesity (Davis_PNAS_2007).; SCV000712198: Animal models in mice have shown that this variant causes Bardet-Biedl syndrome (Davis 2007).; SCV003539679: Functional studies in zebrafish lacking BBS1 and co-injected with wildtype mRNA and this mutation demonstrated only a partial rescue, consistent with a possible hypomorphic effect of this variant (Zaghloul, 2010).; SCV004120938: "In vivo and in vitro studies suggest that this variant impacts protein function (Davis et al. 2007. PubMed ID: 18032602; Zaghloul et al. 2010. PubMed ID: 20498079)."
PM1
In a hotspot region, there are 2 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 13 uncertain in NM_024649.5
PP5
Variant 11-66526181-T-G is Pathogenic according to our data. Variant chr11-66526181-T-G is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 12143.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP4
Computational evidence support a benign effect (MetaRNN=0.08079672). . Strength limited to SUPPORTING due to the PP5.
BS2
High Homozygotes in GnomAdExome4 at 2 AR geneVariant has number of homozygotes lower than other variant known as pathogenic in the gene, so the strength is limited to Supporting.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_024649.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BBS1
NM_024649.5
MANE Select
c.1169T>Gp.Met390Arg
missense
Exon 12 of 17NP_078925.3
ZDHHC24
NM_001348571.2
c.*21+755A>C
intron
N/ANP_001335500.1E9PLR9

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
BBS1
ENST00000318312.12
TSL:1 MANE Select
c.1169T>Gp.Met390Arg
missense
Exon 12 of 17ENSP00000317469.7Q8NFJ9-1
ENSG00000256349
ENST00000419755.3
TSL:2
c.1280T>Gp.Met427Arg
missense
Exon 12 of 17ENSP00000398526.3
BBS1
ENST00000393994.4
TSL:1
c.782T>Gp.Met261Arg
missense
Exon 9 of 13ENSP00000377563.2Q8NFJ9-3

Frequencies

GnomAD3 genomes
AF:
0.00205
AC:
312
AN:
152210
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000892
Gnomad AMI
AF:
0.0307
Gnomad AMR
AF:
0.00262
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000659
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00290
Gnomad OTH
AF:
0.00143
GnomAD2 exomes
AF:
0.00151
AC:
380
AN:
251388
AF XY:
0.00163
show subpopulations
Gnomad AFR exome
AF:
0.000492
Gnomad AMR exome
AF:
0.000838
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000924
Gnomad NFE exome
AF:
0.00276
Gnomad OTH exome
AF:
0.00147
GnomAD4 exome
AF:
0.00274
AC:
4010
AN:
1461852
Hom.:
2
Cov.:
31
AF XY:
0.00268
AC XY:
1952
AN XY:
727236
show subpopulations
African (AFR)
AF:
0.000478
AC:
16
AN:
33478
American (AMR)
AF:
0.00101
AC:
45
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86258
European-Finnish (FIN)
AF:
0.000786
AC:
42
AN:
53418
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.00338
AC:
3756
AN:
1111982
Other (OTH)
AF:
0.00250
AC:
151
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
193
386
578
771
964
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
156
312
468
624
780
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00205
AC:
312
AN:
152328
Hom.:
0
Cov.:
32
AF XY:
0.00215
AC XY:
160
AN XY:
74488
show subpopulations
African (AFR)
AF:
0.000890
AC:
37
AN:
41580
American (AMR)
AF:
0.00262
AC:
40
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5182
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4820
European-Finnish (FIN)
AF:
0.000659
AC:
7
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00290
AC:
197
AN:
68038
Other (OTH)
AF:
0.00142
AC:
3
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
15
30
45
60
75
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00228
Hom.:
1
Bravo
AF:
0.00210
TwinsUK
AF:
0.00351
AC:
13
ALSPAC
AF:
0.00363
AC:
14
ESP6500AA
AF:
0.000682
AC:
3
ESP6500EA
AF:
0.00268
AC:
23
ExAC
AF:
0.00148
AC:
180
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00262
EpiControl
AF:
0.00296

ClinVar

ClinVar submissions
Significance:Pathogenic/Likely pathogenic
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
25
-
-
Bardet-Biedl syndrome 1 (26)
12
-
-
not provided (12)
10
-
-
Bardet-Biedl syndrome (11)
4
-
-
Retinal dystrophy (4)
3
-
-
Retinitis pigmentosa (3)
1
-
-
BBS1-related disorder (1)
1
-
-
Inborn genetic diseases (1)
1
-
-
Retinal disorder (1)
1
-
-
See cases (1)
1
-
-
Severe early-childhood-onset retinal dystrophy (1)
1
-
-
Usher syndrome (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.85
BayesDel_addAF
Uncertain
0.084
D
BayesDel_noAF
Pathogenic
0.35
CADD
Uncertain
25
DANN
Uncertain
0.98
DEOGEN2
Uncertain
0.75
D
Eigen
Uncertain
0.49
Eigen_PC
Uncertain
0.49
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.92
D
M_CAP
Uncertain
0.12
D
MetaRNN
Benign
0.081
T
MetaSVM
Uncertain
0.73
D
MutationAssessor
Uncertain
2.2
M
PhyloP100
4.7
PrimateAI
Uncertain
0.71
T
PROVEAN
Uncertain
-4.0
D
REVEL
Pathogenic
0.66
Sift
Uncertain
0.012
D
Sift4G
Uncertain
0.0080
D
Polyphen
0.73
P
Vest4
0.98
MVP
0.94
MPC
0.38
ClinPred
0.070
T
GERP RS
4.5
Varity_R
0.90
gMVP
0.95
Mutation Taster
=14/86
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
Splicevardb
2.0
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs113624356; hg19: chr11-66293652; COSMIC: COSV99041500; COSMIC: COSV99041500; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.